Search for Clinical Trial Results
Prostatic Hyperplasia - 40 Studies Found
Status | Study |
Completed |
Study Name: Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) Condition: Benign Prostatic Hyperplasia Date: 2011-10-24 Interventions:
|
Completed |
Study Name: Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2012-12-21 Interventions: Drug: Silodosin 8 mg daily for 24 weeks |
Completed |
Study Name: A Study Comparing Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2010-10-08 Interventions: Device: GreenLight XPS vs. TURP GreenLight XPS laser conso |
Completed |
Study Name: A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). Condition: Prostatic Hyperplasia Date: 2002-08-22 Interventions: Drug: ML-04A |
Recruiting |
Study Name: Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams Condition: Prostatic Hyperplasia Date: 2015-03-12 Interventions: Device: Embosphere Microspheres |
Completed |
Study Name: Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2008-08-07 Interventions:
|
Completed |
Study Name: Saw Palmetto Extract in Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2002-05-16 Interventions: Drug: Saw Palmetto |
Not yet recruiting |
Study Name: Prostatic Hyperplasia Treatment and Cancer Prevention Condition: Prostatic Hyperplasia Date: 2016-12-12 Interventions:
|
Terminated |
Study Name: Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2005-10-10 Interventions: Drug: Lonidamine |
Completed |
Study Name: Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2009-04-27 Interventions:
|